TITAN PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - CONSENT OF ODENBERG, ULLAKKO, MURANISHI & CO., LLP - March 25, 2011

Attached files

file filename
10-K - ANNUAL REPORT ON FORM 10-K - TITAN PHARMACEUTICALS INCd10k.htm
EX-31.1 - CERTIFICATION OF THE PRINCIPAL EXEC AND FIN OFFICER PURSUANT TO RULE 13(A)-14(A) - TITAN PHARMACEUTICALS INCdex311.htm
EX-32.1 - CERTIFICATE OF THE PRINCIPAL EXEC AND FIN OFFICER PURSUANT TO 18 U.S. 1350 - TITAN PHARMACEUTICALS INCdex321.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-171181) of our report dated March 25, 2011 relating to the consolidated financial statements of Titan Pharmaceuticals, Inc. as of December 31, 2010 and 2009 and for each of the three years in the period ended December 31, 2010.

/s/ ODENBERG, ULLAKKO, MURANISHI & CO. LLP

San Francisco, California

March 25, 2011

Stock widget

Investing forum

TITAN PHARMACEUTICALS INC Reports

Also read